Biotech sector right now is actually in worse shape than it was in 2008 in some measures believe it or not. A bounceback has to occur at some point.
25% of small-mid cap biotechs (under $5b USD) currently trading under cash, versus 18% during 2008 GFC. How dos that make any sense at all. I am eagerly awaiting the recovery
valuation thoughts, page-312
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(4.17%) |
Mkt cap ! $11.21M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $2.657K | 235.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1428738 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 1368900 | 6 |
View Market Depth
| Last trade - 11.54am 06/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |